By 2027, the worldwide spinal fusion devices market is projected to reach $8.9 billion, according to Emergen Research.
Spinal Tech
Full-year 2020 revenue for SeaSpine declined 3 percent year over year to $154.3 million, according to the company's March 1 earnings report.
Here's how Medtronic, Stryker and Johnson & Johnson's shares have fluctuated over the last five days.
Bioventus, a medical technology company, will pay millions of dollars to resolve allegations it violated the False Claims Act.
An upcoming Supreme Court decision stemming from the patent dispute between Arthrex and Smith+Nephew could affect patent cases going forward, according to The New York Times.
Devicemaker Aurora Spine on March 1 launched its Silo posterior sacroiliac joint fusion system.
Devicemaker Empirical Spine initiated the premarket approval process for use of the LimiFlex paraspinous tension band with a decompression for patients suffering from degenerative spondylolisthesis with lumbar spinal stenosis.
NuVasive posted net sales of $291.8 million in the fourth quarter, a 6 percent decrease compared to the same period in 2019.
Device company Aurora Spine said Feb. 24 that it received loan proceeds of $350,140 under the second round of the Paycheck Protection Program, as part of the Coronavirus Aid, Relief and Economic Security Act.
Medtronic Chair and CEO Geoff Martha was optimistic about sales of its spine surgery robot increasing in the coming year during the company's Feb. 23 third-quarter conference call, as transcribed by The Motley Fool.
